Vertex Pharma scientist talks about the long road to developing non
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles
Georgia court candidate sues to block ethics rules so he can keep campaigning on abortion
ATLANTA (AP) — A former Democratic congressman running for Georgia State Supreme Court filed a feder2024-05-07Ecuador rations electricity as drought persists in the northern Andes
QUITO, Ecuador (AP) — Ecuador on Tuesday began to ration electricity in the country’s main cities as2024-05-07Mesmerising charts show world's most and least populated countries over time
MailOnline's spell-binding chart tracks how the populations of the world's largest and smallest nati2024-05-07The Biden administration recruits 15 states to help enforce airline consumer laws
The Biden administration is enlisting the help of officials in 15 states to enforce consumer-protect2024-05-07How major US stock indexes fared Monday, 5/6/2024
U.S. stocks closed higher on Wall Street, adding to last week’s gains.The S&P 500 climbed 1% Mon2024-05-07Olympic gold is great, but athletes say some cash to go with it is even better
NEW YORK (AP) — They compete for a trophy, a ring, the chance to be called a champion and, sometimes2024-05-07
atest comment